Doubling immunochemistry laboratory testing efficiency with the cobas e 801 module while maintaining consistency in analytical performance.

OBJECTIVES The new immunochemistry cobas e 801 module (Roche Diagnostics) was developed to meet increasing demands on routine laboratories to further improve testing efficiency, while maintaining high quality and reliable data. DESIGN AND METHODS During a non-interventional multicenter evaluation study, the overall performance, functionality and reliability of the new module was investigated under routine-like conditions. It was tested as a dedicated immunochemistry system at four sites and as a consolidator combined with clinical chemistry at three sites. RESULTS We report on testing efficiency and analytical performance of the new module. Evaluation of sample workloads with site-specific routine request patterns demonstrated increased speed and almost doubled throughput (maximal 300 tests per h), thus revealing that one cobas e 801 module can replace two cobas e 602 modules while saving up to 44% floor space. Result stability was demonstrated by QC analysis per assay throughout the study. Precision testing over 21 days yielded excellent results within and between labs, and, method comparison performed versus the cobas e 602 module routine results showed high consistency of results for all assays under study. In a practicability assessment related to performance and handling, 99% of graded features met (44%) or even exceeded (55%) laboratory expectations, with enhanced reagent management and loading during operation being highlighted. CONCLUSION By nearly doubling immunochemistry testing efficiency on the same footprint as a cobas e 602 module, the new module has a great potential to further consolidate and enhance laboratory testing while maintaining high quality analytical performance with Roche platforms.

[1]  Mario Plebani,et al.  Clinical laboratories: production industry or medical services? , 2015, Clinical chemistry and laboratory medicine.

[2]  M. Panteghini,et al.  Imprecision of tumour biomarker measurements on Roche Modular E170 platform fulfills desirable goals derived from biological variation , 2010, Annals of clinical biochemistry.

[3]  Holger Moch,et al.  The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report , 2016, PloS one.

[4]  W Stockmann,et al.  Criteria of practicability , 1993 .

[5]  A. V. van Gammeren,et al.  Analytical performance evaluation of the Cobas 6000 analyzer – special emphasis on trueness verification , 2008, Clinical chemistry and laboratory medicine.

[6]  Graham Jones,et al.  cobas 8000 Modular Analyzer Series Evaluated under Routine-like Conditions at 14 Sites in Australia, Europe, and the United States , 2013, Journal of laboratory automation.

[7]  Margaret McGovern,et al.  An Innovative Approach to Functionality Testing of Analysers in the Clinical Laboratory , 2008, Journal of automated methods & management in chemistry.

[8]  G. Lippi,et al.  Laboratory economics. Risk or opportunity? , 2016, Clinical chemistry and laboratory medicine.

[9]  Mario Plebani,et al.  Shop for quality or quantity? Volumes and costs in clinical laboratories , 2012, Clinical chemistry and laboratory medicine.

[10]  Dieter J. Vonderschmitt,et al.  Multicentre performance evaluation of the E170 Module for MODULAR ANALYTICS , 2004, Clinical chemistry and laboratory medicine.